buy silagra online uk buy motilium canada purchase clomid online canada cheap viagra fast delivery

Investor Relations

Communiqués en persberichten

Oproepingsbrief Metrics in Balance NV_Buitengewone Algemene Vergadering op 29 maart 2019 & Jaarlijkse Algemene Vergadering 27 mei 2019

Oproepingsbrief Jaarlijkse Algemene Vergadering Metrics in Balance NV_28 mei 2018

Press release Metrics in Balance N.V. – Listing on Euronext AccessTM in Paris

Document de présentation – mars 2018

Publications Belgian Official Gazette

03-04-2018 (wijziging mandaat gedelegeerd bestuurder)
29-03-2018 (Vermenigvuldiging aantal aandelen – kapitaalverhoging door inbreng in geld – ontslag bestuurder – kwijting – benoeming bestuurder)
03-11-2016 (oprichting)

KBO – Metrics in Balance NV_29.03.2018
Metrics in Balance NV Gecoördineerde Statuten_29.03.2019

Jaarrekening Metrics in Balance NV_per 31 december 2017
Jaarrekening Metrics in Balance NV_per 31 december 2018

Codes

ISIN-code : BE0974328602
LEI-code : 9676001O8J81JR4HH394

Company-code: 0665.584.108

 

Directors

  • Dirk Verstraete, managing director
  • Guy De Vreese, managing director
  • Philippe Van Acker, director
  • Cavalli Consulting BVBA, represented by Marc Gryspeerdt, director


Shareholder’s Structure

  • Share capital: EUR 12.438.001,27
  • Number of outstanding shares as of March 29, 2019: 4.390.523
  • Number of voting rights as of March 29, 2019: 4.390.523
  • Each of the shares carries one voting right at the general meeting of shareholders No outstanding options or warrants have been issued that entitle their holder to shares, nor shares without voting rights.
  • Ultimate Beneficial Owner (UBO):
    On March 29th, 2019 REMEDENT NV held 1.316.546 MiB shares representing circa 29,99% of MiB’s total share capital and voting rights.
    REMEDENT NV is for 99,99% owned by the American company Remedent Inc. stock listed on Nasdaq (https://www.nasdaq.com/markets/spos/company/remedent-inc-71235-55437). According to the last know shareholders’ records of Remedent Inc. dating from May 8th, 2018, no shareholder was owner of more than 25% of the shares of Remedent Inc. Since Mr. De Vreese is director of Remedent Inc., Mr. Guy De Vreese will be indicated as an indirect UBO of Metrics in Balance NV.


Contactpersoon

Dirk Verstraete
tel: +32 474 86 25 74
mail: info@metricsinbalance.com


Maatschappelijke zetel  

Zuiderlaan 1-3 bus 8
9000 Gent, Belgium

 

Euronext Access(TM) Paris : Euronext website

Meest recente notering: Metrics in Balance (MLMIB)